The main benefit of CAR T cell therapy is that it successfully treats many people with blood cancers who have run out of treatment options.
This is clearly shown by the results of a clinical trial that used the CAR T cell therapy we use at The London Clinic (Yescarta, which is also known as axicabtagene ciloleucel).
The trial involved more than 100 people with large B-cell lymphoma whose cancer was still spreading after at least two previous treatments.
Out of this number, approximately half saw their cancer disappear completely, and nearly a third saw their cancer partly reduce.
Shorter treatment times
Your CAR T cell therapy will usually involve a one-off treatment followed by your care team monitoring you every day for less than two weeks.
Stem cell transplants also usually require just a single treatment. However, the whole process for a stem cell transplant can take months.
This is because of what needs to happen before the transplant and the long time it takes to recover from it.
Similarly, chemotherapy can take months to complete. This is because it typically involves multiple cycles of treatment and recovery.
Effective for years
The changes made to T cells in the laboratory mean they commonly last in a person’s body for several years.
As a result, CAR T cells may continue to find and destroy cancer cells long after the original cancer it was targeting has disappeared.
In contrast, traditional chemotherapy is only effective at killing cancer cells during and shortly after it’s been given to a person.
This means if cancer returns, a person needs to restart chemotherapy (or another treatment) to destroy the cancer cells.
A safer option
CAR T cell therapy doesn’t require aggressive chemotherapy, which can lead to severe side effects.
Patients receiving CAR T cells also don’t usually require immunosuppression, a treatment that reduces the body’s ability to fight infections and other diseases.
In contrast, immunosuppression is required before a stem cell transplant.